<DOC>
	<DOCNO>NCT01149954</DOCNO>
	<brief_summary>The purpose study compare rate extent absorption ibuprofen 200 mg gelcaps ( test ) versus Advil liquigels ( reference ) administer 1 x 200 mg gelcap feed condition .</brief_summary>
	<brief_title>Bioequivalence Study Ibuprofen 200 mg Soft Gel Capsules Dr. Reddy 's Laboratories Limited Under Fed Conditions</brief_title>
	<detailed_description>Randomized , 2-way crossover , bioequivalence study Ibuprofen 200 mg gel capsule Advil liquigels 200 mg gel cap administer 1 x 200 mg gel capsule healthy subject feed condition .</detailed_description>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Subjects females and/or male , smoker and/or nonsmoker , 18 year age old . Clinically significant illness within 4 week administration study medication . Clinically significant surgery within 4 week prior administration study medication . Any clinically significant abnormality find medical screening . Any reason , opinion medical subinvestigator , would prevent subject participate study . Abnormal laboratory test judge clinically significant . Positive urine drug screen screen . Positive test hepatitis B , hepatitis C screening . ECG abnormality ( clinically significant ) vital sign abnormality ( systolic blood pressure low 90 140 mmHg , diastolic blood pressure low 50 90 mmHg ; heart rate less 50 100 bpm ) screening . Subjects Body Mass Index ( BMI ) â‰¥30.0 . History significant alcohol abuse within six month screen visit indication regular use fourteen unit alcohol per week ( 1 unit = 150 mL wine 360 mL beer 45 mL alcohol 40 % ) . History drug abuse use illegal drug : use soft drug ( marijuana ) within 3 month screen visit hard drug ( cocaine , phencyclidine ( PCP ) crack ) within 1 year screen visit . History allergic reaction ibuprofen NSAIDs ( e.g . aspirin , diclofenac , diflunisal , etodolac , ketoprofen , fenoprofen , floctafenine , flurbiprofen , indomethacin , ketorolac , mefenamic acid , nabumetone , naproxen , oxaprozin , piroxicam , salsalate , sulindac , tenoxicam , tiaprofenic acid tolmetin ) . History allergic reaction heparin . Use drug know induce inhibit hepatic drug metabolism ( examples inducer : barbiturate , carbamazepine , phenytoin , glucocorticoid , rifampin/rifabutin ; examples inhibitor : antidepressant , cimetidine , diltiazem , erythromycin , ketoconazole , Mono Amine Oxadise ( MAO ) inhibitor , neuroleptic , verapamil , quinidine ) within 30 day prior administration study medication . Use investigational drug participation investigational study within 30 day prior administration study medication . History presence clinically significant gastrointestinal pathology ( e.g . chronic diarrhea , inflammatory bowel disease ) , unresolved gastrointestinal symptom ( e.g . diarrhea , vomit ) , liver kidney disease condition know interfere absorption , distribution , metabolism excretion drug . Any history presence clinically significant neurological , endocrinal , cardiovascular , pulmonary , hematologic , immunologic , psychiatric metabolic disease . Use prescription medication within 14 day prior administration study medication overthecounter product ( include natural food supplement , vitamin , garlic supplement ) within 7 day prior administration study medication , except topical product without systemic absorption . Any food allergy , intolerance , restriction special diet , opinion medical subinvestigator , contraindicate subject 's participation study . Subjects depot injection implant drug 3 month prior administration study medication . Donation plasma ( 500 mL ) within 7 day . Donation loss whole blood prior administration study medication follow : less 300 mL whole blood within 30 day 300 mL 500 mL whole blood within 45 day 500 mL whole blood within 56 day . Subjects consume food beverage contain grapefruit ( e.g . fresh , can , frozen ) within 7 day prior administration study medication . Subjects history know presence active peptic ulcer heartburn . Subjects history know presence gastrointestinal bleeding . Subjects history know presence bronchospastic reactivity ( e.g . asthma ) . For female : Breastfeeding subject . Positive urine pregnancy test screening ( performed female ) . Female subject childbearing potential unprotected sexual intercourse nonsterile male partner ( i.e . male sterilized vasectomy least 6 month ) within 14 day prior study drug administration . The acceptable method contraception : Condom + spermicide Diaphragm + spermicide Intrauterine contraceptive device ( place least 4 week prior study drug administration ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>Crossover</keyword>
	<keyword>Ibuprofen</keyword>
</DOC>